32426-80-5

Basic information

• Product Name: (Z)-((prop-1-en-1-yloxy)methyl)benzene
• Synonyms: (Z)-((prop-1-en-1-yloxy)methyl)benzene
• CAS NO: 32426-80-5
• Molecular Weight: 148.205
• Mol File: 32426-80-5.mol
• Article Data: 13

Chemical Properties

• CAS DataBase Reference: (Z)-((prop-1-en-1-yloxy)methyl)benzene(CAS DataBase Reference)
• NIST Chemistry Reference: (Z)-((prop-1-en-1-yloxy)methyl)benzene(32426-80-5)
• EPA Substance Registry System: (Z)-((prop-1-en-1-yloxy)methyl)benzene(32426-80-5)

Safety Data

• Hazardous Substances Data: 32426-80-5(Hazardous Substances Data)

Upstream product

• 14593-43-2 benzyl allyl ether 
• 55775-43-4 2-Chloro-3,4-epoxy-4-phenylbutane 
• 13807-91-5 benzyloxy-2-propanol 
• 36004-04-3 ethyl (E)-1-phenylbut-1-en-3-ol 
• 4426-63-5 3,4-Epoxy-4-phenylbutan-2-ol 
• 23556-91-4 1-((1-(benzyloxy)propoxy)methyl)benzene 

Downstream Products

• 18192-20-6 cis-1-Phenyl-1-trimethylsilyloxy-buten-⁽²⁾ 
• 746-47-4 tetrabenzo[5.5]fulvalene 
• 2071-44-5 di-fluoren-9-ylidene-hydrazine 
• 1453495-55-0 (S)-2-(benzyloxy)butanenitrile 
• 52755-39-2 (2E)-1-phenylbut-2-en-1-ol 
• 35660-91-4 (E)-1-phenyl-2-buten-1-one 
• 912877-15-7 (E)-4-Benzyloxy-3-methyl-2-oxo-but-3-enoic acid methyl ester 
• 2032-33-9 N-benzyl-N-propylamine 
• 99398-31-9 trans,cis,trans-2-phenyl-3,5-dimethyl-4-(benzyloxy)piperidine 
• 118921-95-2 (3S^*,4S^*,4aR^*)-3-(benzyloxy)-1,4-dimethyl-2-(phenylsulfonyl)-2,3,4,4a,5,6,7,8-octahydroisoquinoline 
• 118922-03-5 (2R,3R,4R)-1-Benzenesulfonyl-2-benzyloxy-3-methyl-4-phenyl-1,2,3,4-tetrahydro-pyridine 
• 118922-03-5 (2R,3R,4S)-1-Benzenesulfonyl-2-benzyloxy-3-methyl-4-phenyl-1,2,3,4-tetrahydro-pyridine 
• 118922-03-5 (2R^*,3S^*,4R^*)-2-(benzyloxy)-3-methyl-4-phenyl-1-(phenylsulfonyl)-1,2,3,4-tetrahydropyridine 
• 127032-99-9 (2R^*,3R^*,4S^*)-2-(benzyloxy)-6-(ethoxycarbonyl)-3-methyl-4-phenyl-1-(phenylsulfonyl)-1,2,3,4-tetrahydropyridine 

Relevant articles and documents

8-AMINOISOQUINOLINE CompoundS AND USES THEREOF

3-Carbonylamino-8-aminoisoquinoline Compounds of formula (I): variations thereof, and their use as inhibitors of HPK1 (hematopoietic kinase 1) are described. The Compounds are useful in treating HPK1-dependent disorders and enhancing an immune response. Also described are methods of inhibiting HPK1, methods of treating HPK1-dependent disorders, methods for enhancing an immune response, and methods for preparing the 3-carbonylamino-8-aminoisoquinoline Compounds.

Ruthenium(IV)-catalyzed isomerization of the C=C bond of O-allylic substrates: A theoretical and experimental study

A general mechanism to rationalize RuIV-catalyzed isomerization of the C=C bond in O-allylic substrates is proposed. Calculations supporting the proposed mechanism were performed at the MPWB1K/6-311+G(d,p)+SDD level of theory. All experimental observations in different solvents (water and THF) and under different pH conditions (neutral and basic) can be interpreted in terms of the new mechanism. Theoretical analysis of the transformation from precatalyst to catalyst led to structural identification of the active species in different media. The experimentally observed induction period is related to the magnitudes of the energy barriers computed for that process. The theoretical energy profile for the catalytic cycle requires application of relatively high temperatures, as is experimentally observed. Participation of a water molecule in the reaction coordinate is mechanistically essential when the reaction is carried out in aqueous medium.

Synthesis of tert-alkyl amino hydroxy carboxylic esters via an intermodular ene-type reaction of oxazolones and enol ethers

terf-Alkyl amino hydroxy carboxylic acids are abundantly present within the structure of many biologically active natural products. We describe herein the synthesis of these substrates using an oxazolone-mediated ene-type reaction with enol ethers followed by NaBH4 reduction of the intermediate oxazolone.